Funding & Deals
Sep 10, 2026 · 1 min read · 68,265 views
Pfizer, Lilly 'most favored nation' deals to give US share of revenue from raised foreign prices
L
Liam Turner
Editorial · Sep 10, 2026
Reports indicate that the "most favored nation" drug pricing deals that Pfizer and Eli Lilly signed with the Trump administration suggest the companies will give the government a share of increased revenue they generate from raising prices abroad
← Previous
HHS rolls out sweeping clinical trial reforms to counter China, RFK Jr. says
Next →
Gilead gets another HIV treatment approval, extending lenacapavir's dominance
